Business

Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change

Financial Post · September 22, 2026 at 5:02 p.m.

TORONTO, Sept.

22, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change

More from Financial Post

How Fast Will Charging Be in the Future? 2026 Chery International User Summit to Unlock Next-Gen Smart Energy Experience

CGTN: Breaking Through: Why the Long March Still Matters to China and the World

Paladin Announces Availability of Notice of Meeting for Annual General Meeting

Prime Drink Group Announces Subscription Receipt Financing and Closing of Second Tranche of Private Placement of Units

More in Business

How Fast Will Charging Be in the Future? 2026 Chery International User Summit to Unlock Next-Gen Smart Energy Experience

CGTN: Breaking Through: Why the Long March Still Matters to China and the World

Paladin Announces Availability of Notice of Meeting for Annual General Meeting

Prime Drink Group Announces Subscription Receipt Financing and Closing of Second Tranche of Private Placement of Units

Solera | Hollander Showcases the Next Era of Automotive Recycling at ARA 2026

Purecore Upsizes Non-Brokered Private Placement to $3.5M